Lubner David Charles Insider Trades

Insider Trading History

Track insider trading activity for Lubner David Charles. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dyne Therapeutics
Dyne Therapeutics DYN
Director
Holding Value $712k 35,152 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$599k 35,152 shares
$17.04
$20.26
Catalyst Biosciences
Catalyst Biosciences CBIO
Director
Holding Value $193k 11,050 shares
Last Trade
Jun 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$188k 11,050 shares
$17.01
$17.50
Arcellx
Arcellx ACLX
Director
Holding Value $0 0 shares
Last Trade
Apr 28, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$2.49M 21,659 shares
$115.00
$115.07
Arcellx
Arcellx ACLX
Director
Holding Value $0 0 shares
Last Trade
Apr 28, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$22.4M 195,007 shares
$115.07
$115.07
Dyne Therapeutics
Dyne Therapeutics DYN
Director
Holding Value $0 0 shares
Last Trade
Apr 24, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$979k 53,625 shares
$18.26
$20.26
Arcellx
Arcellx ACLX
Director
Holding Value $2.49M 21,659 shares
Last Trade
Jan 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$450k 6,000 shares
$75.00
$115.07
Arcellx
Arcellx ACLX
Director
Holding Value $6.84M 59,405 shares
Last Trade
Jan 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$433k 6,000 shares
$72.17
$115.07
Arcellx
Arcellx ACLX
Director
Holding Value $3.18M 27,659 shares
Last Trade
Jan 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$433k 6,000 shares
$72.17
$115.07
CARGO Therapeutics
CARGO Therapeutics CRGX
Director
Holding Value $0 0 shares
Last Trade
Aug 19, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$109k 25,000 shares
$4.35
$4.47
Catalyst Biosciences
Catalyst Biosciences CBIO
Director
Holding Value $158k 9,023 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$138k 9,023 shares
$15.30
$17.50
CARGO Therapeutics
CARGO Therapeutics CRGX
Director
Holding Value $112k 25,000 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$109k 25,000 shares
$4.35
$4.47
Catalyst Biosciences
Catalyst Biosciences CBIO
Director
Holding Value $0 0 shares
Last Trade
Jun 13, 2025 Sale
$323k 20,164 shares
$16.00
$17.50
Dyne Therapeutics
Dyne Therapeutics DYN
Director
Holding Value $709k 35,000 shares
Last Trade
May 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$419k 35,000 shares
$11.96
$20.26
Arcellx
Arcellx ACLX
Director
Holding Value $1.06M 9,174 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$584k 9,174 shares
$63.68
$115.07
Vor Biopharma
Vor Biopharma VOR
Director
Holding Value $446k 30,000 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.7k 30,000 shares
$0.19
$14.85
Arcellx
Arcellx ACLX
Director
Holding Value $922k 8,011 shares
Last Trade
May 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$411k 8,011 shares
$51.30
$115.07
Vor Biopharma
Vor Biopharma VOR
Director
Holding Value $446k 30,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$14.85
Dyne Therapeutics
Dyne Therapeutics DYN
Director
Holding Value $509k 25,133 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$792k 25,133 shares
$31.53
$20.26
POINT Biopharma Global
POINT Biopharma Global PNT
Director
Holding Value $0 0 shares
Last Trade
Dec 27, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.24M 98,963 shares
$12.50
$12.50
POINT Biopharma Global
POINT Biopharma Global PNT
Director
Holding Value $45k 3,600 shares
Last Trade
Dec 26, 2023 Sale (Tender)Reported as Tender on SEC Form 4.
$443k 35,400 shares
$12.50
$12.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up